Graduate Training in the Pharmacological Sciences
药理学研究生培训
基本信息
- 批准号:10628838
- 负责人:
- 金额:$ 42.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
Modern drug discovery and development require the training of scientists who understand the
molecular, physiological and quantitative basis of drug action and specificity, and who can apply modern
technologies and concepts to the development of novel therapeutic strategies. This multidisciplinary doctoral
training program in the Pharmacological Sciences is designed to help meet that demand by preparing students
for biomedical research careers in schools of medicine, dentistry and pharmacy, in research institutes, and in
governmental or industrial laboratories. The most important component of training is laboratory research, first
as a series of research rotations, then in the dissertation laboratory. This training is complemented by core
courses in pharmacology that emphasize quantitative analysis of drug action, pharmacokinetics, drug
disposition, biostatistics and experimental design, in addition to ethics training, seminar courses, journal clubs,
and advanced courses in specialty areas. Emphasis throughout is placed on training in rigor and
reproducibility, professional development, research ethics, and the refinement of communication skills. The 54
training faculty members represent 16 basic science and clinical departments at Emory, thereby providing a
wealth of diverse research training opportunities. This is an application for a new program, which would
replace the current program that has successfully trained a diverse cohort of students for the biomedical
workforce over the past two decades. We plan to continue our track record of training success while also
introducing new and innovative aspects to the training together with evidence-based mechanisms to evaluate
both student and program outcomes. We are requesting 8 positions, with the typical duration of appointment
being 24 months. Graduates of this program will have acquired broad familiarity with pharmacology, deep
knowledge in the area of dissertation research, and the technical, communicative and analytical skills
necessary to succeed in the biomedical workforce. The research conducted by the trainees in this program will
advance our knowledge of disease processes and contribute to the discovery of novel therapeutic strategies
that will benefit the health of our citizens. By preparing young scientists to contribute to and lead the nation’s
efforts in these areas, this training program will help to ensure that our ability to improve the nation’s health
remains strong in the future.
项目摘要
现代药物的发现和开发需要培训了解药物的科学家。
药物作用和特异性的分子,生理和定量基础,以及谁可以应用现代
新的治疗策略的发展的技术和概念。这位多学科博士
药理学科学的培训计划旨在通过培养学生来帮助满足这一需求
在医学,牙科和药学院,研究机构,
政府或工业实验室。培训最重要的组成部分是实验室研究,首先是
作为一系列的研究轮换,然后在论文实验室。这项培训由核心
药理学课程,强调药物作用的定量分析,药代动力学,药物
处置,生物统计学和实验设计,除了道德培训,研讨会课程,期刊俱乐部,
和专业领域的高级课程。重点放在整个培训的严谨性和
可重复性,专业发展,研究道德和沟通技巧的完善。的54
培训教师代表埃默里大学的16个基础科学和临床部门,从而提供了一个
丰富多样的研究培训机会。这是一个新项目的申请,
取代目前的计划,已成功地培养了一批多样化的学生,为生物医学
劳动力在过去的二十年。我们计划继续我们的培训成功的记录,同时也
在培训中引入新的和创新的方面,同时建立循证机制,
学生和项目的成果。我们要求8个职位,与典型的任期
24个月。该计划的毕业生将获得广泛的熟悉药理学,深入
在论文研究领域的知识,以及技术,沟通和分析能力
在生物医学领域取得成功所必需的。该计划的受训人员进行的研究将
推进我们对疾病过程的了解,并有助于发现新的治疗策略
这将有利于我们公民的健康。通过培养年轻的科学家为国家的发展做出贡献,
通过在这些方面的努力,这项培训计划将有助于确保我们提高国民健康水平的能力。
在未来依然强大。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Randy A. Hall其他文献
PDZ interactions between PHLPP phosphatases and the NHERF scaffold
PHLPP 磷酸酶和 NHERF 支架之间的 PDZ 相互作用
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
M. Kunkel;E. Garcia;Randy A. Hall;A. Newton - 通讯作者:
A. Newton
Effects of cyclothiazide on synaptic responses in slices of adult and neonatal rat hippocampus.
环噻嗪对成年和新生大鼠海马切片突触反应的影响。
- DOI:
- 发表时间:
1994 - 期刊:
- 影响因子:1.7
- 作者:
John Larson;To;Randy A. Hall;Gary Lynch - 通讯作者:
Gary Lynch
Secタンパク質膜透過装置の活写にむけて
Sec蛋白膜渗透装置的实时成像
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Dan Zhu;Chenchen Li;Andrew M. Swanson;Rosa M. Villalba;Jidong Guo;Zhaobin Zhang;Shannon Matheny;Tatsuro Murakami;Jason R. Stephenson;Sarah Daniel;Masaki Fukata;Randy A. Hall;Jeffrey J. Olson;Gretchen N. Neigh;Yoland Smith;Donald G. Rainnie,;塚崎 智也,春山 隆充 ,菅野 泰功,田中 良樹 ,紺野 宏記 - 通讯作者:
塚崎 智也,春山 隆充 ,菅野 泰功,田中 良樹 ,紺野 宏記
Mini Review Adhesion G Protein-Coupled Receptors: Signaling, Pharmacology & Mechanisms of Activation
迷你回顾粘附 G 蛋白偶联受体:信号传导、药理学
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
K. Paavola;Randy A. Hall - 通讯作者:
Randy A. Hall
Mice lacking full length Adgrb1 (Bai1) exhibit social deficitsem,/em increased seizure susceptibility, and altered brain development
缺乏全长 Adgrb1(Bai1)的小鼠表现出社交缺陷、癫痫易感性增加和大脑发育改变。
- DOI:
10.1016/j.expneurol.2022.113994 - 发表时间:
2022-05-01 - 期刊:
- 影响因子:4.200
- 作者:
Fu Hung Shiu;Jennifer C. Wong;Takahiro Yamamoto;Trisha Lala;Ryan H. Purcell;Sharon Owino;Dan Zhu;Erwin G. Van Meir;Randy A. Hall;Andrew Escayg - 通讯作者:
Andrew Escayg
Randy A. Hall的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Randy A. Hall', 18)}}的其他基金
Disease-Associated Mutations and Ligand Activation of the Adhesion G Protein-Coupled Receptor ADGRB2
粘附 G 蛋白偶联受体 ADGRB2 的疾病相关突变和配体激活
- 批准号:
10811019 - 财政年份:2023
- 资助金额:
$ 42.44万 - 项目类别:
Control of Seizure and Migraine Susceptibility by GPR37L1
GPR37L1 控制癫痫和偏头痛易感性
- 批准号:
10449353 - 财政年份:2021
- 资助金额:
$ 42.44万 - 项目类别:
Control of Seizure and Migraine Susceptibility by GPR37L1
GPR37L1 控制癫痫和偏头痛易感性
- 批准号:
10279634 - 财政年份:2021
- 资助金额:
$ 42.44万 - 项目类别:
Control of Seizure and Migraine Susceptibility by GPR37L1
GPR37L1 控制癫痫和偏头痛易感性
- 批准号:
10651823 - 财政年份:2021
- 资助金额:
$ 42.44万 - 项目类别:
Activation and Regulation of the Synaptic Receptor BAI1
突触受体 BAI1 的激活和调节
- 批准号:
9900070 - 财政年份:2019
- 资助金额:
$ 42.44万 - 项目类别:
BAI2 mutation associated with a novel neurological disorder
BAI2 突变与新型神经系统疾病相关
- 批准号:
8877775 - 财政年份:2015
- 资助金额:
$ 42.44万 - 项目类别:
GPR37L1 mutation associated with a novel neurological disorder
GPR37L1 突变与新型神经系统疾病相关
- 批准号:
8871619 - 财政年份:2015
- 资助金额:
$ 42.44万 - 项目类别:
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke
探地雷达37
- 批准号:
8753503 - 财政年份:2014
- 资助金额:
$ 42.44万 - 项目类别:
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke
探地雷达37
- 批准号:
9464568 - 财政年份:2014
- 资助金额:
$ 42.44万 - 项目类别:
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke
探地雷达37
- 批准号:
9117648 - 财政年份:2014
- 资助金额:
$ 42.44万 - 项目类别:
相似海外基金
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in at-risk Older Adults
同时进行有氧运动和认知训练可预防高危老年人的阿尔茨海默病
- 批准号:
10696409 - 财政年份:2023
- 资助金额:
$ 42.44万 - 项目类别:
Comparative effectiveness of pelvic floor muscle training, Mirabegron, and Trospium among older women with urgency urinary incontinence and high fall risk: a feasibility randomized clinical study.
盆底肌肉训练、米拉贝隆和曲司氯胺对患有急迫性尿失禁和高跌倒风险的老年女性的效果比较:一项可行性随机临床研究。
- 批准号:
10648299 - 财政年份:2023
- 资助金额:
$ 42.44万 - 项目类别:
The Pain Identification and Communication Toolkit: A Training Program to Support Family Caregivers of Persons with ADRD
疼痛识别和沟通工具包:支持 ADRD 患者家庭护理人员的培训计划
- 批准号:
10570403 - 财政年份:2023
- 资助金额:
$ 42.44万 - 项目类别:
Motivation Skills Training to Enhance Functional Outcomes for People with Schizophrenia
动机技能培训可增强精神分裂症患者的功能结果
- 批准号:
10572192 - 财政年份:2023
- 资助金额:
$ 42.44万 - 项目类别:
Examining the contributions of placebo effects in cognitive training
检查安慰剂效应在认知训练中的贡献
- 批准号:
10390772 - 财政年份:2022
- 资助金额:
$ 42.44万 - 项目类别:
Examining the contributions of placebo effects in cognitive training
检查安慰剂效应在认知训练中的贡献
- 批准号:
10630072 - 财政年份:2022
- 资助金额:
$ 42.44万 - 项目类别: